UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going

Critical reviews in oncology/hematology, 2017-09, Vol.117, p.38-47

2017

Volltextzugriff (PDF)

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

ESMO open, 2022-04, Vol.7 (2), p.100406-100406, Article 100406

2022

Volltextzugriff (PDF)

The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy

Critical reviews in oncology/hematology, 2018-10, Vol.130, p.1-12

2018

Volltextzugriff (PDF)

The role of Aurora-A inhibitors in cancer therapy

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi47-vi52

2007

Volltextzugriff (PDF)

Photography as a therapeutic tool to re-elaborate “cancer” experience

Annals of oncology, 2017-10, Vol.28, p.vi87-vi88

2017

Volltextzugriff (PDF)

1893 The role of Androgen Receptor, E-cadherin and Ki67 as novel prognostic markers in Triple Negative Breast Cancer (TNBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S297-S297

2015

Volltextzugriff (PDF)

Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study)

Annals of oncology, 2018-10, Vol.29, p.viii102-viii102

2018

Volltextzugriff (PDF)

Efficacy and safety of the combination of pertuzumab (P) plus trastuzumab (T) plus docetaxel (D) for HER-2 positive metastatic breast cancer (MBC) in pretreated patients (pts) with trastuzumab in the neo/adjuvant setting: a retrospective real-life study

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi41

2017

Volltextzugriff (PDF)

Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung

Annals of oncology, 2017-10, Vol.28, p.vi78-vi78

2017

Volltextzugriff (PDF)

Baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR) and platelet-to-lymphocyte ratio (PLR) and outcome in non small cell lung cancer (NSCLC) treated with nivolumab or docetaxel: a preliminary analysis

Annals of oncology, 2017-10, Vol.28, p.vi61-vi61

2017

Volltextzugriff (PDF)

Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study

Annals of oncology, 2019-07, Vol.30, p.iv115-iv115

2019

Volltextzugriff (PDF)

Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi40

2017

Volltextzugriff (PDF)

Photochromic Switches Incorporated in Bridging Ligands: A New Tool to Modulate Energy-Transfer Processes

Advanced functional materials, 2006-01, Vol.16 (2), p.195-208

2006

Volltextzugriff (PDF)

Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi53-vi57

2007

Volltextzugriff (PDF)

Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406]

ESMO open, 2022-04, Vol.7 (2), p.100471-100471, Article 100471

2022

Volltextzugriff (PDF)

47P TREATMENT OPTIONS FOR SMALL CELL LUNG CANCER: DOES LANREOTIDE REPRESENT A NEW CHOICE?

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S20-S21

2013

Volltextzugriff (PDF)

Bortezomib: a new pro-apoptotic agent in cancer treatment

Current cancer drug targets, 2010-02, Vol.10 (1), p.55-67

2010

Volltextzugriff (PDF)

Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience

European journal of cancer (1990), 2012-03, Vol.48 (5), p.642-647

2012

Volltextzugriff (PDF)

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

Oncology, 2012-01, Vol.83 (2), p.108-116

2012

Volltextzugriff (PDF)

Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy

Annals of oncology, 2006-04, Vol.17 (suppl-2), p.ii73-ii75

2006

Volltextzugriff (PDF)

Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?

European journal of obstetrics & gynecology and reproductive biology, 2005-09, Vol.122 (1), p.127-128

2005

Volltextzugriff (PDF)

P39.09 Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S469-S469

2021

Volltextzugriff (PDF)

THE BEHAVIOUR OF ELDERLY PATIENTS TREATED WITH CHEMORADIATION. A SINGLE INSTITUTION EXPERIENCE

Radiotherapy and oncology, 2011, Vol.98, p.S13-S13

2011

Volltextzugriff (PDF)

P2.16-38 Efficacy and Safety of Target Therapy and Immunotherapy in Advanced NSCLC in Elderly: A Systematic Review of Real World Studies

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S880-S881

2019

Volltextzugriff (PDF)

1 – 25 von 598

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(525)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy

The role of Aurora-A inhibitors in cancer therapy

Photography as a therapeutic tool to re-elaborate “cancer” experience

1893 The role of Androgen Receptor, E-cadherin and Ki67 as novel prognostic markers in Triple Negative Breast Cancer (TNBC)

Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study)

Efficacy and safety of the combination of pertuzumab (P) plus trastuzumab (T) plus docetaxel (D) for HER-2 positive metastatic breast cancer (MBC) in pretreated patients (pts) with trastuzumab in the neo/adjuvant setting: a retrospective real-life study

Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung

Baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR) and platelet-to-lymphocyte ratio (PLR) and outcome in non small cell lung cancer (NSCLC) treated with nivolumab or docetaxel: a preliminary analysis

Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study

Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study

Photochromic Switches Incorporated in Bridging Ligands: A New Tool to Modulate Energy-Transfer Processes

Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study

Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients

Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406]

47P TREATMENT OPTIONS FOR SMALL CELL LUNG CANCER: DOES LANREOTIDE REPRESENT A NEW CHOICE?

Bortezomib: a new pro-apoptotic agent in cancer treatment

Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy

Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?

P39.09 Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic

THE BEHAVIOUR OF ELDERLY PATIENTS TREATED WITH CHEMORADIATION. A SINGLE INSTITUTION EXPERIENCE

P2.16-38 Efficacy and Safety of Target Therapy and Immunotherapy in Advanced NSCLC in Elderly: A Systematic Review of Real World Studies

Aktive Filter

Suchergebnisse filtern